|
 
The first and only state association devoted entirely to nurse practitioners!

|
|

|
Continuing Education Information
The American Association of Nurse Practitioners® accredits the MS Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number:1640685. Activities are planned in accordance with AANP Accreditation Standards and Policies. MANP is approved to provide continuing education through 10/31/2026. MANP has been approved to provide continuing education for the following:
- Mississippi Board of Nursing
- Arkansas Board of Nursing
- Florida Board of Nursing
- Any Board of Nursing that accepts AANP-accredited CE.
- CE Broker
Speakers, please review the information if you would like to be considered as a speaker for a MANP event. Click the blue button below for more information about presenting at one of our live events. All of our speaking opportunities are voluntary, and all travel or overnight accommodations are at the speaker's expense. The registration fee is waived; however, our organization can only offer nurse practitioners continuing education credits for sessions that they attend. Our organization can provide (upon request) a letter of affirmation regarding the presentation at the event for the presenter's accreditation body. Contact our office at [email protected] for questions or further information.
|
|
|

|
|
| |
|
Wednesday, January 14, 2026
Virtual (Live, not Pre-recorded) Event
MANP DOT FMCSA MEDICAL EXAMINER'S TRAINING COURSE
8:00am - 5:30pm
MANP is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 1640685 Activity ID: 20250221-05. This activity is approved for 9 contact hours. This activity was planned in accordance with AANP Accreditation Standards and Policies. MANP has designated 1 contact hour of the 9 total hours as related to controlled substances.
For questions, please call the MANP OFFICE 601-407-3226
This course is live, not pre-recorded, and is not available as a self-paced or on-demand course.

CANCELLATION POLICY: A cancellation charge of $50.00 will be applied to refund requests in writing, emailed to [email protected] before 01/01/2026. NO REFUNDS will be granted after the cancellation deadline of 01/01/2026. The cancellation policy is strictly enforced. Fees for Join & Go that are applied to membership ($300) are not refundable. The cancellation policy is strictly enforced.
|
Ridgeland: Thursday, January 15
Time: 6:00-8:00 pm
Presentation by Vertex Pharmaceuticals
The role of suzetrigine in acute pain management
Koestler Prime
1000 Highland Colony Pkwy #6001
Ridgeland, MS 39157
Deadline for Pre-Registration: January 12, 2025, Maximum seating 28
Attendees must complete the pre-registration form to confirm a seat.
Register here: https://forms.gle/BsDZ34e5xMmSRXE99
Alethea Hill, PhD, ACNP-BC, MS Pharm
Senior Medical Science Liaison, Pain, Alabama/Mississippi Territory
Cell phone: (205) 457-3666 Email: [email protected]
Vertex Pharmaceuticals, Incorporated www.vrtx.com
|
Jackson: Tuesday, January 27 from 1:30pm-4:00pm
[This event is Free. We have to provide a headcount to the Capitol Security]

|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
Save the Date

Hotel Room Block Open Jan 2, 2026
Attendee Registration Opens Jan 2, 2026
Exhibitor Registration Opens Jan 2, 2026
|
|
|
| |
| |
|
MANP reserves the right to adjust, alter, and/or cancel an event at any point leading up to and during the event date without liability. By registering for this event, you are granting permission to MANP to share your email information with our attending exhibitors/sponsors. Also, you consent to MANP using your name, portrait, picture, or photograph as part of the MANP events, activities, events, and social media publications. Because the conferences serve as an open forum, opinions expressed and/or materials distributed by program participants do not necessarily reflect or imply advocacy or endorsement by the MANP, its officers, or members. Also, MANP does not endorse any specific commercial products or services.
|
|
|
|
|